UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 18, 2005
----------------
ABLE LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
- --------------------------------------------------------------------------------
Delaware 001-11352 04-3029787
- --------------------------------------------------------------------------------
(State or other (Commission File Number) (IRS Employer
jurisdiction of Identification Number)
incorporation)
- --------------------------------------------------------------------------------
1 Able Drive, Cranbury, NJ 08512
(Address of Principal Executive Offices) (Zip Code)
(609) 495-2800
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
|_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
|_| Pre-commencement communications pursuant to Rue 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
Item 1.03 Bankruptcy or Receivership.
On July 18, 2005, Able Laboratories, Inc. (the "Company") filed a
voluntary petition for relief under Chapter 11 of the United States Bankruptcy
Code (the "Bankruptcy Code") in the United States Bankruptcy Court for the
District of New Jersey (the "Bankruptcy Court"). The Company will continue to
operate its business and manage it properties and assets as a
"debtor-in-possession" under the jurisdiction of the Bankruptcy Court and in
accordance with the applicable provisions of the Bankruptcy Code. On July 18,
2005, the Company issued a press release relating to the foregoing. A copy of
the press release is attached hereto as Exhibit 99.1 and is incorporated in its
entirety herein by reference.
Item 9.01 Financial Statements and Exhibits
(a) Financial Statements of Businesses Acquired:
Not Applicable.
(b) Pro Forma Financial Information:
Not Applicable.
(c) Exhibits:
99. Press Release, dated July 18, 2005
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ABLE LABORATORIES, INC.
By: /s/ Paul D. Cottone
----------------------------------
Name: Paul D. Cottone
Dated: July 20, 2005 Title: Chief Restructuring Officer
INDEX TO EXHIBITS
Sequentially
Exhibit Numbered
Number Exhibit Page
- ------- ------- ------------
99.1 Press Release, dated July 18, 2005 4